| Breakdown | TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 56.23B | 55.30B | 53.56B | 53.72B | 62.91B | 63.46B |
| Gross Profit | 11.33B | 11.05B | 11.82B | 11.51B | 12.26B | 13.41B |
| EBITDA | 4.07B | 4.09B | 4.72B | 4.47B | 5.46B | 8.61B |
| Net Income | 2.51B | 2.53B | 2.77B | 3.26B | 3.13B | 6.54B |
Balance Sheet | ||||||
| Total Assets | 41.53B | 41.77B | 39.91B | 37.00B | 38.49B | 38.60B |
| Cash, Cash Equivalents and Short-Term Investments | 3.15B | 3.69B | 3.24B | 3.11B | 3.15B | 4.30B |
| Total Debt | 9.70B | 10.88B | 10.90B | 10.74B | 12.29B | 8.78B |
| Total Liabilities | 38.13B | 42.12B | 41.23B | 38.07B | 41.52B | 40.25B |
| Stockholders Equity | 3.41B | -346.00M | -1.32B | -1.07B | -3.02B | -1.64B |
Cash Flow | ||||||
| Free Cash Flow | 2.88B | 2.80B | 3.16B | 2.96B | 3.67B | 5.83B |
| Operating Cash Flow | 3.71B | 3.70B | 3.75B | 3.57B | 4.46B | 6.41B |
| Investing Cash Flow | -1.15B | -1.18B | -646.00M | -590.00M | -3.55B | -1.01B |
| Financing Cash Flow | -2.30B | -2.06B | -3.08B | -2.89B | -2.07B | -5.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $92.68B | 8.79 | 64.18% | 0.18% | -16.35% | 316.56% | |
70 Outperform | $82.60B | 26.06 | -889.39% | 1.02% | 31.56% | 106.00% | |
70 Outperform | $113.54B | 13.34 | -218.24% | 1.45% | 19.12% | 39.59% | |
64 Neutral | $20.82B | 14.44 | 116.57% | 1.89% | 2.64% | 4.12% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | $13.30B | 10.90 | 13.33% | ― | 12.22% | -48.34% | |
57 Neutral | $17.67B | 8.26 | 1135.29% | 5.09% | 4.09% | -5.77% |